Close
Help
Login
Staff Login
Register
FR
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Hide details
Conceptually similar
CP119568721 | Here's what to know about Johnson & Johnson's COVID-19 vaccine
CP120124021 | AstraZeneca COVID-19 vaccine now recommended for Canadian seniors
CP122883921 | What to do if you think you have rare case of VITT
CP124342421 | Manitoba approves different second dose after AstraZeneca COVID-19 vaccine
CP121580021 | How to talk to your vaccine hesitant friends
CP112540921 | Should you worry about buying gift cards during the COVID-19 pandemic?
CP122883960 | Camping gear is hard to find in the COVID-19 pandemic
CP122883962 | Camping gear is hard to find in the COVID-19 pandemic
CP122770871 | All approved COVID-19 vaccines safe, effective: Trudeau
CP119759571 | Le vaccin de Johnson & Johnson approuvé
Placeline/People
City
Vaughan
Country
Canada
What to know about Johnson & Johnson's COVID-19 vaccine
Here's what to know about the Johnson & Johnson vaccine.
Clinical trials suggest it reduced severe COVID-19 illness by 85 per cent.
It prevented 100 per cent of COVID-related hospitalization or death.
Vaccines from Pfizer, Moderna and Oxford-AstraZeneca also had zero hospitalizations and deaths in their trials.
J&J was 72 per cent effective in preventing COVID infections after 28 days in the company's U.S. trials.
The efficacy dropped to 66 per cent when averaging in results from other trials, including a South African study that factored in more transmissible variants .
Pfizer and Moderna showed 95 per cent efficacy in their trials that were done before new variants emerged .
Johnson & Johnson requires only one dose.
It can be stored in a regular fridge.
Pfizer and Moderna require freezers, but AstraZeneca can be stored in a fridge.
The U.S. FDA said the most common reported side effects were headache and fatigue, followed by muscle aches, nausea and fever
Actions
Add to collection
Add to cart
Information
Source name:
The Canadian Press
Unique identifier:
CP119565630
Legacy Identifier:
baa29981f081f4632a86de26e043ef3ea
Type:
Video
Duration:
1m39s
Dimensions:
1920px × 1080px 46.79 MB
Usage rights:
FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.
Create Date:
3/5/2021 5:14:00 PM
Display aspect ratio:
16:9
Tags
COVID-19
pandemic